The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
CRISPR And CRISPR-Associated Genes-Global Market Insights and Sales Trends 2024
Synopsis
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
The global CRISPR And CRISPR-Associated Genes market size is expected to reach US$ 1770.3 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of CRISPR And CRISPR-Associated Genes in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Academic Institutes and Research and Development Institutes, are propelling CRISPR And CRISPR-Associated Genes market. Genome Editing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Engineering segment is estimated at % CAGR for the next seven-year period.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CRISPR And CRISPR-Associated Genes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CRISPR And CRISPR-Associated Genes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CRISPR And CRISPR-Associated Genes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CRISPR And CRISPR-Associated Genes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CRISPR And CRISPR-Associated Genes covered in this report include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich and Precision Biosciences, etc.
The global CRISPR And CRISPR-Associated Genes market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Global CRISPR And CRISPR-Associated Genes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRISPR And CRISPR-Associated Genes market, Segment by Type:
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Global CRISPR And CRISPR-Associated Genes market, by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CRISPR And CRISPR-Associated Genes companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
The global CRISPR And CRISPR-Associated Genes market size is expected to reach US$ 1770.3 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of CRISPR And CRISPR-Associated Genes in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Academic Institutes and Research and Development Institutes, are propelling CRISPR And CRISPR-Associated Genes market. Genome Editing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Engineering segment is estimated at % CAGR for the next seven-year period.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CRISPR And CRISPR-Associated Genes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CRISPR And CRISPR-Associated Genes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CRISPR And CRISPR-Associated Genes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CRISPR And CRISPR-Associated Genes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CRISPR And CRISPR-Associated Genes covered in this report include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich and Precision Biosciences, etc.
The global CRISPR And CRISPR-Associated Genes market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Global CRISPR And CRISPR-Associated Genes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRISPR And CRISPR-Associated Genes market, Segment by Type:
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Global CRISPR And CRISPR-Associated Genes market, by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CRISPR And CRISPR-Associated Genes companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of CRISPR And CRISPR-Associated Genes
1.1 CRISPR And CRISPR-Associated Genes Market Overview
1.1.1 CRISPR And CRISPR-Associated Genes Product Scope
1.1.2 CRISPR And CRISPR-Associated Genes Market Status and Outlook
1.2 Global CRISPR And CRISPR-Associated Genes Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2029)
1.4 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Region (2018-2023)
1.5 Global CRISPR And CRISPR-Associated Genes Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CRISPR And CRISPR-Associated Genes Market Size (2018-2029)
1.6.1 North America CRISPR And CRISPR-Associated Genes Market Size (2018-2029)
1.6.2 Europe CRISPR And CRISPR-Associated Genes Market Size (2018-2029)
1.6.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size (2018-2029)
1.6.4 Latin America CRISPR And CRISPR-Associated Genes Market Size (2018-2029)
1.6.5 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size (2018-2029)
2 CRISPR And CRISPR-Associated Genes Market by Type
2.1 Introduction
2.1.1 Genome Editing
2.1.2 Genetic Engineering
2.1.3 GRNA Database/Gene Librar
2.1.4 CRISPR Plasmid
2.1.5 Human Stem Cells
2.1.6 Genetically Modified Organisms/Crops
2.1.7 Cell Line Engineering
2.2 Global CRISPR And CRISPR-Associated Genes Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Type (2018-2023)
2.2.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CRISPR And CRISPR-Associated Genes Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CRISPR And CRISPR-Associated Genes Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CRISPR And CRISPR-Associated Genes Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CRISPR And CRISPR-Associated Genes Revenue Breakdown by Type (2018-2029)
3 CRISPR And CRISPR-Associated Genes Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Academic Institutes
3.1.4 Research and Development Institutes
3.2 Global CRISPR And CRISPR-Associated Genes Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Application (2018-2023)
3.2.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CRISPR And CRISPR-Associated Genes Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CRISPR And CRISPR-Associated Genes Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CRISPR And CRISPR-Associated Genes Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CRISPR And CRISPR-Associated Genes Revenue Breakdown by Application (2018-2029)
4 CRISPR And CRISPR-Associated Genes Competition Analysis by Players
4.1 Global CRISPR And CRISPR-Associated Genes Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRISPR And CRISPR-Associated Genes as of 2022)
4.3 Date of Key Players Enter into CRISPR And CRISPR-Associated Genes Market
4.4 Global Top Players CRISPR And CRISPR-Associated Genes Headquarters and Area Served
4.5 Key Players CRISPR And CRISPR-Associated Genes Product Solution and Service
4.6 Competitive Status
4.6.1 CRISPR And CRISPR-Associated Genes Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.1.4 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Editas Medicine
5.2.1 Editas Medicine Profile
5.2.2 Editas Medicine Main Business
5.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.2.4 Editas Medicine CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.2.5 Editas Medicine Recent Developments
5.3 Caribou Biosciences
5.3.1 Caribou Biosciences Profile
5.3.2 Caribou Biosciences Main Business
5.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.3.4 Caribou Biosciences CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.3.5 CRISPR therapeutics Recent Developments
5.4 CRISPR therapeutics
5.4.1 CRISPR therapeutics Profile
5.4.2 CRISPR therapeutics Main Business
5.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.4.4 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.4.5 CRISPR therapeutics Recent Developments
5.5 Intellia therapeutics, Inc.
5.5.1 Intellia therapeutics, Inc. Profile
5.5.2 Intellia therapeutics, Inc. Main Business
5.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.5.4 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.5.5 Intellia therapeutics, Inc. Recent Developments
5.6 Cellectis
5.6.1 Cellectis Profile
5.6.2 Cellectis Main Business
5.6.3 Cellectis CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.6.4 Cellectis CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.6.5 Cellectis Recent Developments
5.7 Horizon Discovery Plc
5.7.1 Horizon Discovery Plc Profile
5.7.2 Horizon Discovery Plc Main Business
5.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.7.4 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.7.5 Horizon Discovery Plc Recent Developments
5.8 Sigma Aldrich
5.8.1 Sigma Aldrich Profile
5.8.2 Sigma Aldrich Main Business
5.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.8.4 Sigma Aldrich CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.8.5 Sigma Aldrich Recent Developments
5.9 Precision Biosciences
5.9.1 Precision Biosciences Profile
5.9.2 Precision Biosciences Main Business
5.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.9.4 Precision Biosciences CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.9.5 Precision Biosciences Recent Developments
5.10 Genscript
5.10.1 Genscript Profile
5.10.2 Genscript Main Business
5.10.3 Genscript CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.10.4 Genscript CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.10.5 Genscript Recent Developments
5.11 Sangamo Biosciences Inc.
5.11.1 Sangamo Biosciences Inc. Profile
5.11.2 Sangamo Biosciences Inc. Main Business
5.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.11.4 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.11.5 Sangamo Biosciences Inc. Recent Developments
5.12 Lonza Group Limited
5.12.1 Lonza Group Limited Profile
5.12.2 Lonza Group Limited Main Business
5.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.12.4 Lonza Group Limited CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.12.5 Lonza Group Limited Recent Developments
5.13 Integrated DNA Technologies
5.13.1 Integrated DNA Technologies Profile
5.13.2 Integrated DNA Technologies Main Business
5.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.13.4 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.13.5 Integrated DNA Technologies Recent Developments
5.14 New England Biolabs
5.14.1 New England Biolabs Profile
5.14.2 New England Biolabs Main Business
5.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.14.4 New England Biolabs CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.14.5 New England Biolabs Recent Developments
5.15 Origene Technologies
5.15.1 Origene Technologies Profile
5.15.2 Origene Technologies Main Business
5.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Products, Services and Solutions
5.15.4 Origene Technologies CRISPR And CRISPR-Associated Genes Revenue (US$ Million) & (2018-2023)
5.15.5 Origene Technologies Recent Developments
6 North America
6.1 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CRISPR And CRISPR-Associated Genes Market Dynamics
11.1 CRISPR And CRISPR-Associated Genes Industry Trends
11.2 CRISPR And CRISPR-Associated Genes Market Drivers
11.3 CRISPR And CRISPR-Associated Genes Market Challenges
11.4 CRISPR And CRISPR-Associated Genes Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
